KMT2E (Histone reader KMT2E) variants and mutations
KMT2E (also known as Histone reader KMT2E) is a human protein-coding gene encoding a histone reader protein. It regulates chromatin and transcription through mechanisms distinct from the catalytic KMT2 methyltransferases and is important for brain development and cell-cycle control. Haploinsufficiency causes O'Donnell-Luria-Rodan syndrome, with developmental delay, intellectual disability, and frequently macrocephaly. This analysis covers 1,961 KMT2E variants and mutations. Of these, 82% have computational variant effect predictions. Disease context includes O'Donnell-Luria-Rodan syndrome, Intellectual disability, and hereditary disease. Example KMT2E variants include S2N, S2R, and I3L.
Variant analysis overview
- Gene: KMT2E
- Protein: Histone reader KMT2E
- UniProt accession: Q8IZD2
- Organism: Homo sapiens
- Variants analyzed: 1961
- Variant scope: all variants
- Completed: 2026-08-20
Variant and mutation evidence
- Variant composition: 1,822 unspecified-consequence records; 73 missense variants; 53 synonymous variants; 4 stop-gained variants; 3 frameshift variants; 3 splice-region variants; 1 in-frame insertions; 2 in-frame deletions
- Prediction scores: 1,606 variants have prediction scores (82% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: O'Donnell-Luria-Rodan syndrome, Intellectual disability, hereditary disease, neurodegenerative disease, Global developmental delay, Seizure, complex neurodevelopmental disorder, autism, neurodevelopmental disorder, Neurodevelopmental delay, lysosomal storage disease, intelligence.
Protein structure and variant hotspots
- Protein features: 1 domains; 8 binding sites; 8 post-translational modification sites.
- Structural context: 77 variants have structural context.
- PTM context: 7 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable KMT2E variants
Examples include S2N, S2R, I3L, I3M, I5F, I5N, I5S, P6A. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- S2N (p.Ser2Asn), Ensembl rs906058851, REVEL 0.56, CADD 26.60
- S2R (p.Ser2Arg), gnomAD 7-105040956-A-C, REVEL 0.83, CADD 27.50
- I3L (p.Ile3Leu), Ensembl rs1795850585
- I3M (p.Ile3Met), TOPMed rs1795850665, REVEL 0.79, CADD 23.90
- I5F (p.Ile5Phe), rs891241557, ClinGen CA164017750, ClinVar RCV003333420, TOPMed rs891241557, REVEL 0.66, CADD 23.90, Uncertain significance, O'Donnell-Luria-Rodan syndrome
- I5N (p.Ile5Asn), rs748387280, ClinGen CA368781887, ClinVar RCV003133949, Uncertain significance, O'Donnell-Luria-Rodan syndrome
- I5S (p.Ile5Ser), ExAC rs748387280, TOPMed rs748387280, gnomAD rs748387280, REVEL 0.84, CADD 24.50
- P6A (p.Pro6Ala), TOPMed rs1795851048, gnomAD rs1795851048, REVEL 0.59, CADD 20.80
- P6T (p.Pro6Thr), gnomAD 7-105040968-C-A, REVEL 0.71, CADD 22.90
- L7L (p.Leu7Leu), rs184187699, gnomAD 7-105040971-T-C, CADD 11.00
- G8A (p.Gly8Ala), ExAC rs749224010, gnomAD rs749224010, REVEL 0.64, CADD 25.90
- G8R (p.Gly8Arg), Ensembl rs569333122, REVEL 0.65, CADD 23.10, Uncertain significance, not provided
- G8W (p.Gly8Trp), gnomAD 7-105040974-G-T, REVEL 0.87, CADD 29.30
- G8E (p.Gly8Glu), gnomAD 7-105040975-G-A, REVEL 0.82, CADD 27.00
- G8G (p.Gly8Gly), gnomAD 7-105040976-G-C, CADD 10.80
- V9I (p.Val9Ile), 1000Genomes rs138858897, ESP rs138858897, ExAC rs138858897, TOPMed rs138858897, REVEL 0.50, CADD 22.50, Uncertain significance, Inborn genetic diseases
- V9F (p.Val9Phe), gnomAD 7-105040977-G-T, REVEL 0.77, CADD 24.10
- D10G (p.Asp10Gly), ESP rs140507140, ExAC rs140507140, gnomAD rs140507140, REVEL 0.45, CADD 23.70
- D10V (p.Asp10Val), gnomAD 7-105040981-A-T, REVEL 0.70, CADD 23.80
- D10D (p.Asp10Asp), gnomAD 7-105040982-T-C, CADD 11.10
- T11I (p.Thr11Ile), rs1435711015, ClinGen CA368781924, cosmic curated COSV57581, ClinVar RCV003671610, REVEL 0.70, CADD 24.40, Uncertain significance, not provided
- T11K (p.Thr11Lys), gnomAD rs1435711015, REVEL 0.71, CADD 23.30, Uncertain significance, not provided
- T11R (p.Thr11Arg), gnomAD 7-105040984-C-G, REVEL 0.69, CADD 24.40
- T11T (p.Thr11Thr), rs1177048633, gnomAD 7-105040985-A-G, CADD 13.50
- A12V (p.Ala12Val), gnomAD 7-105040987-C-T, REVEL 0.44, CADD 24.00
- E13K (p.Glu13Lys), gnomAD 7-105040989-G-A, REVEL 0.49, CADD 24.70
- T14M (p.Thr14Met), Ensembl rs1018642770, REVEL 0.62, CADD 26.40
- T14A (p.Thr14Ala), gnomAD 7-105040992-A-G, REVEL 0.21, CADD 18.90
- T14T (p.Thr14Thr), rs150090175, gnomAD 7-105040994-G-A, CADD 9.42
- S15P (p.Ser15Pro), ExAC rs775235409, TOPMed rs775235409, gnomAD rs775235409, REVEL 0.27, CADD 22.80
- S15* (p.Ser15Ter), gnomAD 7-105040996-C-A, CADD 36.00
- S15S (p.Ser15Ser), gnomAD 7-105040997-A-G, CADD 13.40
- Y16Y (p.Tyr16Tyr), gnomAD 7-105041000-C-T, CADD 9.75
- L17F (p.Leu17Phe), TOPMed rs1795852303, gnomAD rs1795852303, REVEL 0.38, CADD 23.90
- L17L (p.Leu17Leu), gnomAD 7-105041001-T-C, CADD 11.60
- L17S (p.Leu17Ser), gnomAD 7-105041002-T-C, REVEL 0.49, CADD 23.20
- E18G (p.Glu18Gly), rs2129565358, ClinGen CA368781968, ClinVar RCV001760915, Ensembl rs2129565358, Uncertain significance, not provided
- M19K (p.Met19Lys), gnomAD rs1409862009, REVEL 0.81, CADD 24.40, Uncertain significance, Inborn genetic diseases
- M19W (p.Met19Trp), gnomAD 7-105041004-GA-G, CADD 32.00
- A20S (p.Ala20Ser), Ensembl rs2129565359
- A20L (p.Ala20Leu), gnomAD 7-105041008-TG-T, CADD 33.00
- A20T (p.Ala20Thr), gnomAD 7-105041010-G-A, REVEL 0.62, CADD 24.70
- A20D (p.Ala20Asp), gnomAD 7-105041011-C-A, REVEL 0.72, CADD 24.20
- A21T (p.Ala21Thr), gnomAD 7-105041013-G-A, REVEL 0.65, CADD 25.00
- A21E (p.Ala21Glu), gnomAD 7-105041014-C-A, REVEL 0.74, CADD 23.70
- A21V (p.Ala21Val), gnomAD 7-105041014-C-T, REVEL 0.58, CADD 24.60
- A21A (p.Ala21Ala), rs760454347, gnomAD 7-105041015-A-G, CADD 14.00
- G22C (p.Gly22Cys), gnomAD 7-105041016-G-T, REVEL 0.81, CADD 31.00
- G22G (p.Gly22Gly), gnomAD 7-105041018-T-C, CADD 12.90
- S23* (p.Ser23Ter), Ensembl rs1584714647, CADD 36.00
- S23L (p.Ser23Leu), rs1584714647, ClinVar RCV004588938, REVEL 0.78, CADD 24.70, Uncertain significance, not provided
- S23P (p.Ser23Pro), gnomAD 7-105041019-T-C, REVEL 0.69, CADD 25.10
- S23S (p.Ser23Ser), rs1186370216, gnomAD 7-105041021-A-C, CADD 19.00
- E24* (p.Glu24Ter), gnomAD 7-105041022-G-T, CADD 40.00
- E24K (p.Glu24Lys), gnomAD 7-105041022-G-A, REVEL 0.49, CADD 27.80
- E24Q (p.Glu24Gln), gnomAD 7-105041022-G-C, REVEL 0.45, CADD 26.90
- E24V (p.Glu24Val), gnomAD 7-105041023-A-T, REVEL 0.67, CADD 28.10
- P25S (p.Pro25Ser), ExAC rs767867059, gnomAD rs767867059, REVEL 0.65, CADD 28.50
- P25Q (p.Pro25Gln), gnomAD 7-105062166-C-A, REVEL 0.71, CADD 25.70
- P25L (p.Pro25Leu), gnomAD 7-105062166-C-T, REVEL 0.70, CADD 27.40
- P25P (p.Pro25Pro), rs138149088, gnomAD 7-105062167-A-G, CADD 12.80
- S27S (p.Ser27Ser), rs529117650, gnomAD 7-105062173-C-T, CADD 4.82
- V28I (p.Val28Ile), rs367956492, ClinGen CA4423613, NCI-TCGA Cosmic COSV5758, cosmic curated COSV57582, REVEL 0.44, CADD 26.50, Uncertain significance, O'Donnell-Luria-Rodan syndrome; not provided
- V28L (p.Val28Leu), gnomAD 7-105062174-G-T, REVEL 0.50, CADD 27.10
- E29K (p.Glu29Lys), ExAC rs754091887, gnomAD rs754091887, REVEL 0.67, CADD 31.00
- A30A (p.Ala30Ala), gnomAD 7-105062182-T-C, CADD 14.10
- S31R (p.Ser31Arg), Ensembl rs1796842185, REVEL 0.69, CADD 28.50, Uncertain significance, Inborn genetic diseases; not provided
- P32* (p.Pro32Ter), gnomAD 7-105062178-A-AAG, CADD 32.00
- V33M (p.Val33Met), gnomAD 7-105062189-G-A, REVEL 0.43, CADD 27.30
- V33G (p.Val33Gly), gnomAD 7-105062190-T-G, REVEL 0.54, CADD 27.40
- V33E (p.Val33Glu), gnomAD 7-105062190-T-A, REVEL 0.55, CADD 27.50
- V34V (p.Val34Val), rs1009525352, gnomAD 7-105062194-A-G, CADD 12.50
- V35A (p.Val35Ala), rs542916850, ClinGen CA4423616, ClinVar RCV003659143, ClinVar RCV005363165, REVEL 0.34, CADD 23.90, Benign/Likely benign, not provided; Inborn genetic diseases
- V35F (p.Val35Phe), TOPMed rs1303754526, gnomAD rs1303754526, REVEL 0.49, CADD 25.90
- V35I (p.Val35Ile), TOPMed rs1303754526, gnomAD rs1303754526, REVEL 0.29, CADD 22.10
- E36Q (p.Glu36Gln), rs2129567133, ClinGen CA368774114, ClinVar RCV002260805, Ensembl rs2129567133, Uncertain significance, not provided
- E36A (p.Glu36Ala), gnomAD 7-105062199-A-C, REVEL 0.61, CADD 26.70
- K37E (p.Lys37Glu), gnomAD 7-105062201-A-G, REVEL 0.61, CADD 27.80
- K37K (p.Lys37Lys), rs1796842836, gnomAD 7-105062203-A-G, CADD 13.10
- S38S (p.Ser38Ser), gnomAD 7-105062206-C-T, CADD 13.80
- N39S (p.Asn39Ser), ExAC rs779099178, gnomAD rs779099178, REVEL 0.33, CADD 23.10
- N39Y (p.Asn39Tyr), Ensembl rs1484332708, REVEL 0.43, CADD 26.30
- N39I (p.Asn39Ile), gnomAD 7-105062208-A-T, REVEL 0.42, CADD 26.20
- S40G (p.Ser40Gly), gnomAD 7-105062210-A-G, REVEL 0.40, CADD 24.30
- S40N (p.Ser40Asn), gnomAD 7-105062211-G-A, REVEL 0.40, CADD 25.90
- Y41F (p.Tyr41Phe), gnomAD 7-105062214-A-T, REVEL 0.22, CADD 22.00
- Y41Y (p.Tyr41Tyr), rs745763422, gnomAD 7-105062215-T-C, CADD 11.60
- P42R (p.Pro42Arg), gnomAD rs1352067390, REVEL 0.66, CADD 25.80
- P42T (p.Pro42Thr), Ensembl rs778342344
- P42L (p.Pro42Leu), gnomAD 7-105062217-C-T, REVEL 0.63, CADD 26.40
- H43R (p.His43Arg), Ensembl rs975418647, REVEL 0.67, CADD 25.60
- H43H (p.His43His), gnomAD 7-105062221-C-T, CADD 11.40
- Q44Q (p.Gln44Gln), gnomAD 7-105062224-G-A, CADD 9.12
- L45V (p.Leu45Val), gnomAD rs1205018790
- L45L (p.Leu45Leu), rs772104225, gnomAD 7-105062227-A-G, CADD 10.70
- Y46C (p.Tyr46Cys), Ensembl rs1562899790, REVEL 0.54, CADD 28.00
- Y46H (p.Tyr46His), rs1796843653, ClinGen CA368774186, ClinVar RCV003666114, Ensembl rs1796843653, REVEL 0.34, CADD 24.90, Uncertain significance, not provided
- T47A (p.Thr47Ala), gnomAD 7-105062231-A-G, REVEL 0.33, CADD 23.70
- S48G (p.Ser48Gly), rs780152679, ClinGen CA4423620, ClinVar RCV003873685, ClinVar RCV003949079, REVEL 0.38, CADD 26.40, Uncertain significance, not provided
- S48N (p.Ser48Asn), gnomAD 7-105062235-G-A, REVEL 0.43, CADD 26.50
- S49G (p.Ser49Gly), ExAC rs746732435, gnomAD rs746732435, REVEL 0.34, CADD 22.10
- S49S (p.Ser49Ser), rs1264157083, gnomAD 7-105062239-C-T, CADD 10.10
- S50L (p.Ser50Leu), 1000Genomes rs201587183, ExAC rs201587183, TOPMed rs201587183, gnomAD rs201587183, REVEL 0.40, CADD 25.90
- S50P (p.Ser50Pro), ExAC rs768601012, TOPMed rs768601012, gnomAD rs768601012, REVEL 0.36, CADD 25.90
- S50T (p.Ser50Thr), ExAC rs768601012, TOPMed rs768601012, gnomAD rs768601012, REVEL 0.31, CADD 24.60
- S50S (p.Ser50Ser), rs2129567139, gnomAD 7-105062242-A-C, CADD 5.08
- H51Y (p.His51Tyr), Ensembl rs1796844615
- H51R (p.His51Arg), gnomAD 7-105062244-A-G, REVEL 0.49, CADD 24.90
- H52N (p.His52Asn), ExAC rs761573835, gnomAD rs761573835, REVEL 0.36, CADD 24.30
- H54Y (p.His54Tyr), gnomAD 7-105062252-C-T, REVEL 0.62, CADD 25.20
- H54H (p.His54His), gnomAD 7-105062254-C-T, CADD 11.80
- S55G (p.Ser55Gly), TOPMed rs1450060536, gnomAD rs1450060536, REVEL 0.32, CADD 22.50
- S55I (p.Ser55Ile), TOPMed rs1796845005
- S55N (p.Ser55Asn), TOPMed rs1796845005, REVEL 0.33, CADD 26.10
- Y56H (p.Tyr56His), gnomAD rs1365271949
- Y56Y (p.Tyr56Tyr), rs772841711, gnomAD 7-105062260-C-T, CADD 8.43
- I57T (p.Ile57Thr), rs767958893, ClinGen CA4423628, ClinVar RCV002970725, ClinVar RCV005655133, REVEL 0.48, CADD 26.10, Conflicting interpretations, Inborn genetic diseases; not provided
- I57V (p.Ile57Val), cosmic curated COSV57570, ExAC rs759950275, TOPMed rs759950275, gnomAD rs759950275, REVEL 0.30, CADD 23.70, Uncertain significance, not provided
- I57I (p.Ile57Ile), rs1339983380, gnomAD 7-105062263-T-A, CADD 14.50
- G58D (p.Gly58Asp), gnomAD rs1406657297
- G58G (p.Gly58Gly), gnomAD 7-105062266-T-C, CADD 13.40
- A62P (p.Ala62Pro), gnomAD rs1796846071, REVEL 0.60, CADD 33.00
- A62V (p.Ala62Val), gnomAD 7-105062277-C-T, REVEL 0.57, CADD 32.00
- A62E (p.Ala62Glu), gnomAD 7-105062277-C-A, REVEL 0.54, CADD 31.00
- A62A (p.Ala62Ala), gnomAD 7-105062278-G-A, CADD 23.80
- H64N (p.His64Asn), gnomAD 7-105063354-C-A, REVEL 0.67, CADD 26.30
- Y66Y (p.Tyr66Tyr), rs761219973, gnomAD 7-105063362-T-C, CADD 8.99
- p.Gly67 Ala68insProGluTer, gnomAD 7-105063365-T-TCC, CADD 33.00
- G67G (p.Gly67Gly), gnomAD 7-105063365-T-C, CADD 12.60
- p.Ala68 Arg69insGlnTyrTyr, gnomAD 7-105063367-C-CAC, CADD 20.00
- R69H (p.Arg69His), TOPMed rs1490219422, Uncertain significance, Inborn genetic diseases; O'Donnell-Luria-Rodan syndrome
- R69P (p.Arg69Pro), TOPMed rs1490219422
- R69C (p.Arg69Cys), gnomAD 7-105063369-C-T, REVEL 0.53, CADD 32.00
- P70A (p.Pro70Ala), rs2536385139, ClinGen CA368774372, ClinVar RCV003704950, Uncertain significance, not provided
- P71L (p.Pro71Leu), gnomAD 7-105063376-C-T, REVEL 0.69, CADD 26.50
- P72L (p.Pro72Leu), rs747436302, ClinGen CA368774393, cosmic curated COSV57576, ClinVar RCV003013216, REVEL 0.54, CADD 26.40, Likely benign, not provided
- P72R (p.Pro72Arg), TOPMed rs747436302, gnomAD rs747436302, REVEL 0.65, CADD 25.30, Uncertain significance
- P72del (p.Pro72del), gnomAD 7-105063370-GTCC-, CADD 20.60
- P72P (p.Pro72Pro), rs764413185, gnomAD 7-105063380-G-C, CADD 16.60
- P74L (p.Pro74Leu), rs1796900722, ClinGen CA368774409, NCI-TCGA Cosmic COSV9999, cosmic curated COSV99996, Uncertain significance, Inborn genetic diseases
- P74T (p.Pro74Thr), gnomAD rs1342798970, REVEL 0.62, CADD 24.80
- P75L (p.Pro75Leu), rs1234381772, ClinGen CA368774419, NCI-TCGA Cosmic COSV5757, cosmic curated COSV57570, REVEL 0.66, CADD 26.30, Uncertain significance, Inborn genetic diseases; not provided
- P75A (p.Pro75Ala), gnomAD 7-105063387-C-G, REVEL 0.58, CADD 24.90
- P75P (p.Pro75Pro), rs756893449, gnomAD 7-105063389-G-A, CADD 6.28
- A76A (p.Ala76Ala), gnomAD 7-105063392-T-G, CADD 10.60
- S77Y (p.Ser77Tyr), gnomAD 7-105063394-C-A, REVEL 0.73, CADD 25.30
- S77F (p.Ser77Phe), gnomAD 7-105063394-C-T, REVEL 0.69, CADD 26.10
- P78L (p.Pro78Leu), gnomAD 7-105063397-C-T, REVEL 0.72, CADD 26.10
- P80L (p.Pro80Leu), cosmic curated COSV10634, ExAC rs765432325, gnomAD rs765432325, REVEL 0.55, CADD 25.90
- P80del (p.Pro80del), gnomAD 7-105063395-CCCT-, CADD 18.90
- P80S (p.Pro80Ser), gnomAD 7-105063402-C-T, REVEL 0.41, CADD 23.60
- P80A (p.Pro80Ala), gnomAD 7-105063402-C-G, REVEL 0.39, CADD 24.30
- P80P (p.Pro80Pro), gnomAD 7-105063404-A-G, CADD 12.30
- S81L (p.Ser81Leu), rs2536385249, ClinGen CA368774456, ClinVar RCV003322974, Uncertain significance, not provided
- S81P (p.Ser81Pro), rs1480427120, ClinGen CA368774452, ClinVar RCV003444500, gnomAD rs1480427120, REVEL 0.48, CADD 23.80, Uncertain significance, O'Donnell-Luria-Rodan syndrome
- S81S (p.Ser81Ser), rs1251266737, gnomAD 7-105063407-A-G, CADD 12.80
- V82V (p.Val82Val), rs149314039, gnomAD 7-105063410-C-T, CADD 9.31
- L83P (p.Leu83Pro), TOPMed rs1683568677, gnomAD rs1683568677, REVEL 0.55, CADD 26.70, Uncertain significance, Inborn genetic diseases
- I84T (p.Ile84Thr), gnomAD 7-105063415-T-C, REVEL 0.48, CADD 25.40
- S85G (p.Ser85Gly), Ensembl rs2129567227, REVEL 0.36, CADD 23.60
- S85T (p.Ser85Thr), gnomAD 7-105063418-G-C, REVEL 0.39, CADD 23.60
- S85S (p.Ser85Ser), rs766611124, gnomAD 7-105063419-C-T, CADD 12.10
- K86N (p.Lys86Asn), ExAC rs755030634, gnomAD rs755030634, REVEL 0.27, CADD 24.90
- K86T (p.Lys86Thr), ExAC rs751507681, gnomAD rs751507681, REVEL 0.47, CADD 24.60
- K86K (p.Lys86Lys), rs755030634, gnomAD 7-105063422-A-G, CADD 11.40
- E88G (p.Glu88Gly), gnomAD rs1417049068, REVEL 0.57, CADD 28.00
- V89I (p.Val89Ile), gnomAD 7-105063429-G-A, REVEL 0.26, CADD 22.20
- G90S (p.Gly90Ser), 1000Genomes rs552851146, ExAC rs552851146, TOPMed rs552851146, gnomAD rs552851146, REVEL 0.17, CADD 21.80, Uncertain significance, not provided; not specified
- G90V (p.Gly90Val), TOPMed rs1796902123, REVEL 0.49, CADD 23.40, Uncertain significance, not provided
- G90G (p.Gly90Gly), rs747922090, gnomAD 7-105063434-C-T, CADD 12.90
- I91L (p.Ile91Leu), rs1013534993, ClinGen CA368774519, ClinVar RCV002932906, TOPMed rs1013534993, REVEL 0.32, CADD 17.80, Uncertain significance, not provided
- I91V (p.Ile91Val), TOPMed rs1013534993, gnomAD rs1013534993, REVEL 0.27, CADD 16.60, Uncertain significance
- I91M (p.Ile91Met), gnomAD 7-105063437-A-G, REVEL 0.42, CADD 18.70
- F92Y (p.Phe92Tyr), TOPMed rs1796902540
- T93I (p.Thr93Ile), gnomAD 7-105063442-C-T, REVEL 0.40, CADD 22.90
- T94I (p.Thr94Ile), rs755868274, ClinGen CA4423660, ClinVar RCV003878792, ExAC rs755868274, REVEL 0.41, CADD 23.50, Benign, not provided
- T94S (p.Thr94Ser), rs755868274, ClinGen CA368774542, ClinVar RCV002580972, Uncertain significance, not provided
- T94A (p.Thr94Ala), gnomAD 7-105063444-A-G, REVEL 0.23, CADD 20.70
- T94T (p.Thr94Thr), gnomAD 7-105063446-T-C, CADD 11.80
- P95L (p.Pro95Leu), gnomAD 7-105063448-C-T, REVEL 0.53, CADD 23.70
Public KMT2E analysis runs
- KMT2E analysis run — KMT2E (1,961 variants) — completed 2026-08-20